Candida albicans levels in patients with Sjögren's syndrome before and after long-term use of pilocarpine hydrochloride: A pilot study

Quintessence International

Volumn 29, Issue 11, 1998, Pages 705-710

  Rhodus, Nelson L ^a   Liljemark, William ^a   Bloomquist, Cynthia ^a   Bereuter, Janna ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Candida albicans; Pilocarpine hydrochloride; Saliva; Sj gren's syndrome; Xerostomia; Yeast

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; PILOCARPINE;

ADULT; ARTICLE; BACTERIAL COUNT; CANDIDA ALBICANS; DRUG EFFECT; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PILOT STUDY; SALIVA; SALIVATION; SJOEGREN SYNDROME; XEROSTOMIA;

ADULT; CANDIDA ALBICANS; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; MIDDLE AGED; PARASYMPATHOMIMETICS; PILOCARPINE; PILOT PROJECTS; SALIVA; SALIVATION; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 0032195979     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Arendorf TM, Walker DM. The prevalence and intraoral distribution of Candida albicans in man. Arch Oral Biol 1980;25:1-10.
2. Ohman SC, Dahlen G, Moller A, Ohman A. Angular cheilitis: A clinical and microbial study. J Oral Pathol 1986;15:213-217.
3. Budtz-Jorgensen E. Candida-associated denture stomatitis and angular cheilitis. In: Samaramayake LP, MacFarlane TW (eds). Oral Candidiasis. London: Butterworth, 1990:156-183.
4. Parvinen T, Larmas M. The relation of stimulated salivary flow rate and pH to lactobacilli and yeast concentration in saliva. J Dent Res 1981;60:1929-1935.
5. Epstein JB, Pearsall NN, Truelove EL. Qualitative relationships between Candida albicans in saliva and the clinical status of patients. J Clin Microbiol 1980;12:475-478.
6. Epstein JB, Truelove EL, Izutsu K. Oral candidiasis: Pathogenesis and host defense. Rev Infect Dis 1984;6:96-106.
7. Brown LR, Dreizen S, Handler S, Johnson DA. Effect of radiation-induced xerostomia on human oral microflora. J Dent Res 1975; 54:750-754.
8. Rossie KM, Taylor J, Beck FM, Hodgson SE, Blozis GG. Influence of radiation therapy on Candida albicans colonization: A qualitative assessment. Oral Surg Oral Med Oral Pathol 1987;64:698-701.
9. Hauman CHJ, Thompson IO, Theunissen F, Wolfaardt P. Oral carriage of Candida in HIV-seropositive persons. Oral Surg Oral Med Oral Pathol 1993;76:570-572.
10. Navazesh M, Wood GJ, Brightman VJ. Relationship between salivary flow rates and Candida albicans counts. Oral Surg Oral Med Oral Pathol 1995;80:284-288.
11. MacFarlane TW, Mason DK. Changes in the oral flora in Sjögren's syndrome. J Clin Pathol 1974;27:416-419.
12. Tapper-Jones L, Aldred M, Walker DM. Prevalence and intraoral distribution of Candida albicans in Sjögren's syndrome. J Clin Pathol 1980;33:282-287.
13. MacFarlane TW. The oral ecology of patients with severe Sjögren's syndrome. Microbios 1984;41:99-106.
14. Daniels TE, Silverman S, Michalski JP, Greenspan JS, Sylvester RA. The oral component of Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1975;39:875-885.
15. Hernandez YL, Daniels TE. Oral candidiasis in Sjögren's syndrome: Prevalence, clinical correlations and treatment. Oral Surg Oral Med Oral Pathol 1989;68:324-329.
16. Tobji RS, Samaramayake LP, MacFarlane TW. In vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol 1988;3:36-39.
17. Pollock JJ, Denepitiya L, MacKay BJ. Fungistatic and fungicidal activity of human parotid saliva histidine rich polypeptides on Candida albicans. Infect Immun 1984;44:702-707.
18. Kreher JM, Grase GN, Handelman SL, Eisenberg A. Oral yeast, mucosal health and drug use in an elderly denture-wearing population. Spec Care Dent 1991;11:222-226.
19. Mandel ID, Baurmash H. Sialochemistry in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1976;41:182-187.
20. Moutsopoulos HM, Chused TM, Mann D, Klippel JH, Fauci AS, et al. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med 1979;66:733-736.
21. Rhodus NL. Diagnosis and management of the patient with Sjögren's syndrome. Compend Contin Educ Dent 1987;8:578-593.
22. Stuchell RN, Mandel ID, Baurmash H. Clinical utilization of sialochemistry in Sjögren's syndrome. J Oral Pathol 1976;13: 3030-3039.
23. Mandel ID, Katz R. The effect of pilocarpine and a beta-adrenergic blocking agent on human saliva. Pharm Ther Dent 1971;1:71-82.
24. Fox PC, van der Ven PF, Baum BJ, et al. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol 1986;61:243-245.
25. Epstein JB, Schubert MM. Synergistic effect of sialogogues in management of xerostomia after radiation therapy. Oral Surg Oral Med Oral Pathol 1987;64:1179-1182.
26. Rhodus NL, Schuh MJ. The effects of pilocarpine on salivary flow in patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1991;72:945-1949.
27. Valdez IH, Wolff A, Atkinson JC, et al. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer 1993;71:1848-1851.
28. LeVeque FG, Montgomery M, Potter D, et al. A multi-center, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 1993;11:1124-1131.
29. Johnson JT, Ferreti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. New Engl J Med 1993;329:390-395.
30. Ferguson MM. Pilocarpine and other cholinergic drugs in the management of salivary gland dysfunction. Oral Surg Oral Med Oral Pathol 1993;75:186-189.
31. Rhodus NL, Schuh MJ. The effects of pilocarpine on salivary flow in patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1991;72:545-549.
32. Navazesh M, Christensen CM, Brightman VJ. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992;71: 1363-1369.
33. Liljemark WF, Gibbons RJ. Suppression of Candida albicans by human oral streptococci in gnotobiotic mice. Infect Immun 1973;8: 846-849.
34. MacFarlane TW. Etiology and epidemiology of oral Candida. In: Samaramayake LP, MacFarlane TW (eds). Oral Candidiasis. London: Butterworth, 1990:21-46.
35. Wright PS, Clark P, Hardie JM. The prevalence and significance of yeasts in persons wearing complete dentures with soft lining materials. J Dent Res 1985;64:122-125.